| PritorPlus 40 mg/12.5 mg tablets EU/1/02/215/1-5 |
Telmisartan, Hydrochlorothiazide |
Bayer AG |
— |
| PritorPlus 80 mg/12.5 mg tablets EU/1/02/215/006-010 |
Telmisartan, Hydrochlorothiazide |
Bayer AG |
— |
| PritorPlus 80 mg/25 mg tablets EU/1/02/215/15-21 |
Hydrochlorothiazide, Telmisartan |
Bayer AG |
— |
| Privigen 100 mg/ml solution for infusion EU/1/08/446/1-3 |
Human normal immunoglobulin |
CSL Behring GmbH |
— |
| Procoralan 5 mg film-coated tablets EU/1/05/316/1-7 |
Ivabradine |
Les Laboratoires Servier |
— |
| Procoralan 7.5 mg film-coated tablets EU/1/05/316/8-14 |
Ivabradine |
Les Laboratoires Servier |
— |
| PROCYSBI 25 mg gastro-resistant hard capsules EU/1/13/861/001 |
Cysteamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| PROCYSBI 300 mg gastro-resistant granules EU/1/13/861/004 |
Mercaptamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| PROCYSBI 75 mg gastro-resistant granules EU/1/13/861/003 |
Mercaptamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| PROCYSBI 75 mg gastro-resistant hard capsules EU/1/13/861/002 |
Cysteamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| Prolastin 4000 mg, powder and solvent for solution for infusion PA1405/002/002 |
Human alpha1-proteinase inhibitor |
Grifols Deutschland GmbH |
Not marketed |
| Prolastin 5000 mg, powder and solvent for solution for infusion PA1405/002/003 |
Human alpha1-proteinase inhibitor |
Grifols Deutschland GmbH |
Not marketed |
| Prolastin1000mg, powder and solvent for solution for infusion PA1405/002/001 |
Alpha-1-proteinase inhibitor |
Grifols Deutschland GmbH |
Marketed |
| Prolia 60 mg solution for injection in pre-filled syringe EU/1/10/618/1-4 |
Denosumab |
Amgen Europe B.V., |
— |
| Prometax 1.5 mg hard capsules EU/1/98/092/001-003 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 13.3 mg/24 h transdermal patch EU/1/98/092/027-030 |
Rivastigmine |
Almirall, S.A. |
— |
| Prometax 2 mg/ml oral solution EU/1/98/092/013 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 3.0 mg hard capsules EU/1/98/092/004-006 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 4.5 mg hard capsules EU/1/98/092/007-009 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 4.6 mg/24 h transdermal patch EU/1/98/092/19-22 |
Rivastigmine |
Almirall, S.A. |
— |
| Prometax 6.0 mg hard capsules EU/1/98/092/010-012 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 9.5 mg/24 h transdermal patch EU/1/98/092/23-26 |
Rivastigmine |
Almirall, S.A. |
— |
| Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule PA2059/055/001 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, vial PA2059/055/002 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propofol 1% (10 mg/ml) emulsion for injection/infusion PA2059/017/001 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Propofol 1% (10 mg/ml) emulsion for injection/infusion in pre-filled syringe PA2059/017/004 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule PA2059/055/003 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, vial PA2059/055/004 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propofol 2% (20 mg/ml) emulsion for injection/infusion PA2059/017/003 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Propofol 2% (20 mg/ml) emulsion for injection/infusion in pre-filled syringe PA2059/017/005 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propranolol Azure 10 mg film-coated tablets PA22871/031/001 |
Propranolol hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Propranolol Azure 40 mg film-coated tablets PA22871/031/002 |
Propranolol hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| ProQuad powder and solvent for suspension for injection EU/1/05/323/1-13 |
Mumps virus live attenuated jeryl lynn strain, Rubella virus (wistar ra 27/3 strain) live attenuated, Varicella virus vaccine live (oka/merck) |
Merck Sharp & Dohme BV, |
— |
| PROSTAP 3 DCS 11.25 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/001 |
Leuprorelin acetate |
Takeda Products Ireland Ltd |
Marketed |
| PROSTAP 3 DCS 11.25 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PPA0465/473/001 |
Leuprorelin acetate |
PCO Manufacturing Ltd. |
— |
| PROSTAP 6 DCS 30 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/002 |
Leuprorelin acetate |
Takeda Products Ireland Ltd |
Marketed |
| PROSTAP SR DCS 3.75 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/003 |
Leuprorelin acetate |
Takeda Products Ireland Ltd |
Marketed |
| Protaphane EU/1/02/234/016-017 |
Insulin human |
Novo Nordisk A/S |
— |
| Protaphane EU/1/02/234/1-15 |
Insulin human |
Novo Nordisk A/S |
— |
| Protopic 0.03% ointment EU/1/02/201/001 |
Tacrolimus |
LEO Pharma A/S |
— |
| Protopic 0.03% ointment EU/1/02/201/002 |
Tacrolimus |
LEO Pharma A/S |
— |
| Protopic 0.03% ointment EU/1/02/201/005 |
Tacrolimus |
LEO Pharma A/S |
— |
| Protopic 0.1% ointment EU/1/02/201/003 |
Tacrolimus |
LEO Pharma A/S |
— |
| Protopic 0.1% ointment EU/1/02/201/004 |
Tacrolimus |
LEO Pharma A/S |
— |
| Protopic 0.1% ointment EU/1/02/201/006 |
Tacrolimus |
LEO Pharma A/S |
— |
| Protopic 0.1% Ointment EU/1/02/202/003 |
Tacrolimus |
Astellas Pharma GmbH |
— |
| Provigil 100 mg tablets PA25205/001/001 |
Modafinil |
Neuraxpharm Pharmaceuticals S.L. |
Marketed |
| Provigil 200 mg tablets PA25205/001/002 |
Modafinil |
Neuraxpharm Pharmaceuticals S.L. |
Marketed |
| PULMOCIS 2 mg kit for radiopharmaceutical preparation PA0677/003/001 |
Human albumin macro aggregated |
CIS bio International |
Marketed |
| PULMOTEC Kit for radiopharmaceutical preparation PA1034/001/001 |
Graphites |
Cyclomedica Ireland Ltd |
Marketed |